Dopamine protects neurons against glutamate-induced excitotoxicity

Cell Death and Disease

Volumn 4, Issue 1, 2013, Pages

  Vaarmann, A ^a,b   Kovac, S ^a   Holmstrom K M ^a   Gandhi, S ^a   Abramov, A Y ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

calcium; dopamine; excitotoxicity; glutamate

Indexed keywords

CALCIUM; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN REGION; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CYTOSOL; DEPOLARIZATION; DOPAMINERGIC TRANSMISSION; EXCITOTOXICITY; GLIA CELL; HIPPOCAMPUS; MESENCEPHALON; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; APOPTOSIS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CALCIUM; CELLS, CULTURED; DOPAMINE; GLUTAMIC ACID; HIPPOCAMPUS; MESENCEPHALON; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84872183264     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.194     Document Type: Article

References (26)

1. Choi DW. Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 1994; 747: 162-171.
2. Shaw CE, al-Chalabi A, Leigh N. Progress in the pathogenesis of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 2001; 1: 69-76.
3. Schubert D, Piasecki D. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J Neurosci 2001; 21: 7455-7462. (Pubitemid 32904944)
4. Vergun O, Keelan J, Khodorov BI, Duchen MR. Glutamate-induced mitochondrial depolarisation and perturbation of calcium homeostasis in cultured rat hippocampal neurones. J Physiol 1999; 519(Pt 2): 451-466. (Pubitemid 29430008)
5. Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1998; 1: 366-373.
6. Abramov AY, Duchen MR. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Bba-Bioenergetics 2008; 1777: 953-964.
7. Stout AK, Reynolds IJ. High-Affinity calcium indicators underestimate increases in intracellular calcium concentrations associated with excitotoxic glutamate stimulations. Neuroscience 1999; 89: 91-100. (Pubitemid 29049029)
8. Abramov AY, Duchen MR. Impaired mitochondrial bioenergetics determines glutamateinduced delayed calcium deregulation in neurons. BiochimBiophys Acta 2010; 1800: 297-304.
9. Michaels RL, Rothman SM. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J Neurosci 1990; 10: 283-292. (Pubitemid 20059264)
10. Lai TW, Shyu WC, Wang YT. Stroke intervention pathways: NMDA receptors and beyond. Trends Mol Med 2011; 17: 266-275.
11. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci 1995; 18: 57-58.
12. Kotter R. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog Neurobiol 1994; 44: 163-196. (Pubitemid 24295989)
13. Higley MJ, Sabatini BL. Competitive regulation of synaptic Ca2influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci 2010; 13: 958-966.
14. Wang X, Zhong P, Gu Z, Yan Z. Regulation of NMDA Receptors by Dopamine D4 Signaling in Prefrontal Cortex. J Neurosci 2003; 23: 9852-9861. (Pubitemid 37371599)
15. Vaarmann A, Gandhi S, Gourine AV, Abramov AY. Novel pathway for an old neurotransmitter: dopamine-induced neuronal calcium signalling via receptor-independent mechanisms. Cell Calcium 2010; 48: 176-182.
16. Tang TS, Bezprozvanny I. Dopamine receptor-mediated Ca2signaling in striatal medium spiny neurons. J Biol Chem 2004; 279: 42082-42094.
17. Gandhi S, Vaarmann A, Yao Z, Duchen MR, Wood NW, Abramov AY. Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease. PLoS One 2012; 7: e37564.
18. Hartwick AT, Hamilton CM, Baldridge WH. Glutamatergic calcium dynamics and deregulation of rat retinal ganglion cells. J Physiol 2008; 586: 3425-3446. (Pubitemid 352003875)
19. Stanika RI, Villanueva I, Kazanina G, Andrews SB, Pivovarova NB. Comparative impact of voltage-gated calcium channels and NMDA receptors on mitochondria-mediated neuronal injury. J Neurosci 2012; 32: 6642-6650.
20. Vaarmann A, Gandhi S, Abramov AY. Dopamine induces Ca2signaling in astrocytes through reactive oxygen species generated by monoamine oxidase. J Biol Chem 2010; 285: 25018-25023.
21. Surmeier DJ. Calcium, ageing, and neuronal vulnerability in Parkinson's disease. Lancet Neurol 2007; 6: 933-938. (Pubitemid 47405004)
22. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007; 30: 228-235. (Pubitemid 46654239)
23. Chinopoulos C, Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J 2006; 273: 433-450.
24. Jekabsons MB, Nicholls DG. In situ respiration and bioenergetic status of mitochondria in primary cerebellar granule neuronal cultures exposed continuously to glutamate. J Biol Chem 2004; 279: 32989-33000. (Pubitemid 39014759)
25. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991; 254: 1515-1518. (Pubitemid 21917493)
26. Chamoun R, Suki D, Gopinath SP, Goodman JC, Robertson C. Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury. J Neurosurg 2010; 113: 564-570.